EVERGREEN Webinar: Clinical FAQs on T2DM Care, Addressed by Dr V Mohan Dr Jeegar Dattani6 March 2024 12:29 PM ISTThe Evergreen webinar addressed the clinical applicability of Linagliptin and Dapagliflozin in real-world clinical scenarios of type 2 diabetes....
Allergic Rhinitis in Children: Review of Indian Guidelines and Applicability of Fexofenadine Dr. Kamal Kant Kohli28 Feb 2024 11:00 AM ISTAllergic rhinitis is a common disease that frequently occurs in children and adolescents. The disease has a significant burden that impacts sleep,...
Bedtime Ranitidine for Nighttime Acid Reflux: Choose your Option Wisely! Dr. Kamal Kant Kohli15 Feb 2024 11:45 AM ISTNighttime acid reflux commonly referred to as nocturnal acid breakthrough (NAB) is defined as a persistent decrease in intragastric pH below 4 for...
Top 10 Messages from Evergreen Webinar on Clinical Applicability of Linagliptin Dapagliflozin in Type 2 Diabetes, Addressed by Dr V Mohan Dr Jeegar Dattani12 Feb 2024 12:15 PM ISTDr. V. Mohan, M.D., FRCP (London, Edinburgh, Glasgow & Ireland), Ph.D., D.Sc. D.Sc (Hon. Causa), FNASc, FASc, FNA, FACE, FACP, FTWAS, MACP, FRSE....
Indian Guidelines Review on Allergic Rhinitis and Scope for Use of Fexofenadine and Montelukast Combination Dr. Kamal Kant Kohli22 Jan 2024 11:00 AM ISTAllergic Rhinitis and Its Burden in India: Allergic rhinitis (AR) is a common inflammatory condition that affects the nasal mucosa and is...
Considering Ranitidine in Episodic Heartburn Relief-A Practice Perspective Dr. Kamal Kant Kohli18 Jan 2024 11:14 AM ISTHeartburn is a cardinal symptom of gastroesophageal reflux disease (GERD). (1) It is defined as a sensation of burning discomfort in the chest, upper...
Acute Upper Respiratory Tract Infections: Clinical Review and Therapeutic Scope for Using Clarithromycin Dr. Kamal Kant Kohli12 Jan 2024 12:22 PM ISTUpper respiratory tract infections (URTIs) are among the most commonly encountered diseases in primary care settings, accounting for 17.2 billion...
2023 In Review: Major Developments In The Field Of Endocrinology Dr Akhil Krishna26 Dec 2023 11:15 AM IST Let us take a glimpse into the notable progress and accomplishments within the field of endocrinology for the year 2023. This overview showcases...
Linagliptin and Dapagliflozin: Therapeutic Applicability in T2DM with High CV Risk Dr. Kamal Kant Kohli13 Dec 2023 11:48 AM ISTType 2 Diabetes Mellitus and Cardiovascular DiseaseType 2 diabetes mellitus (T2DM) prevalence has been increasing globally, particularly in India (1)...
Allergens in India and its Avoidance: Review through Indian Guidelines and Role of Fexofenadine-Montelukast Combination Dr. Kamal Kant Kohli4 Dec 2023 12:13 PM ISTAllergic rhinitis is one of the most common allergic diseases, which appears to increase in India. Risk factors, diagnosis, and AR management vary...
Safety of Ranitidine: A Fresh Look at an Old Gem Dr. Kamal Kant Kohli23 Nov 2023 11:09 AM ISTThe introduction of histamine type 2 receptor antagonists (H2RAs) has revolutionised the management of acid-related disorders. Ranitidine has been...
Linagliptin and Dapagliflozin: Evidence for Robust Glycemic Control and Reaping CV-CKD Benefits in T2DM (EVERGREEN) Practice Perspective Dr. Kamal Kant Kohli21 Nov 2023 12:14 PM ISTType 2 diabetes mellitus (T2DM) is growing alarmingly due to rapid urbanization, migration, aging population, and lifestyle changes; with Asia being...
